13F-HR filed by Darwin Global Management, Ltd.
Darwin Global Management, Ltd. filed this 13F-HR for the quarter ended 2021-12-31, filed 2022-02-14, with 13 holding rows worth $654,588,000.
- Accession
- 0001420506-22-000465
- Filer
- CIK 1839209
- Filed
- 2022-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2021
A holdings report, 13 entries on the cover page, a total value of $654,588,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $654,588,000 with VALUE read as thousands by filing date, 13F file number 028-21006. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Pfizer Inc. | 717081103 | COM | 7,697,762 | $454,553,000 | thousands by filing date | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 605,587 | $71,605,000 | thousands by filing date | |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 511,908 | $29,819,000 | thousands by filing date | |
| INHIBRX INC | 45720L107 | COM | 591,975 | $25,852,000 | thousands by filing date | |
| BIONTECH SE SPONSORED ADS | 09075V102 | ADR | 90,057 | $23,217,000 | thousands by filing date | |
| ENANTA PHARMACEUTICALS INC | 29251M106 | COM | 166,190 | $12,428,000 | thousands by filing date | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 153,537 | $8,983,000 | thousands by filing date | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 111,500 | $6,524,000 | thousands by filing date | |
| VIR BIOTECHNOLOGY INC | 92764N102 | COM | 145,841 | $6,106,000 | thousands by filing date | |
| CHEMOCENTRYX INC | 16383L106 | COM | 161,802 | $5,891,000 | thousands by filing date | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 317,428 | $5,615,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 216,143 | $3,143,000 | thousands by filing date | |
| VERVE THERAPEUTICS INC | 92539P101 | COM | 23,104 | $852,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-22-000465 | this filing | 2022-02-14 | acceptance time not in the bulk data set |